CGIM
AMED

Cannon Global Investment Management’s Amedisys AMED Stock Holding History

Cannon Global Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,670
Closed -$558K – 69
2025
Q2 		$558K Buy
5,670
+1,870
+49% +$177K 1.14% 23
2025
Q1 		$352K Sell
3,800
-2,200
-37% -$203K 0.62% 38
2024
Q4 		$545K Buy
+6,000
New +$551K 1.18% 31

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cannon Global Investment Management's AMED Position: Q3 2025 in Review

Cannon Global Investment Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 5,670 shares — an estimated $558K sold.

Cannon Global Investment Management first reported a position in AMED in Q4 2024 and held it in 3 quarters. The position peaked at $558K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Cannon Global Investment Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Cannon Global Investment Management sold 5,670 Amedisys shares in Q3 2025, an estimated $558K.
  • Cannon Global Investment Management first reported a position in Amedisys in Q4 2024 and held it in 3 quarters.
  • Cannon Global Investment Management's Amedisys position peaked at $558K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cannon Global Investment Management's 13F filing for Q3 2025, filed 28 Oct 2025.